Bioavailability of clobetasol propionate - Quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping

Skin Pharmacology and Applied Skin Physiology

Volumn 12, Issue 1-2, 1999, Pages 46-53

  Weigmann, Hans Jürgen ^a   Lademann, J ^a   Pelchrzim, R V ^a   Sterry, W ^a   Hagemeister, T ^a   Molzahn, R ^a   Schaefer, M ^a   Lindscheid, M ^a   Schaefer, H ^b   Shah, V P ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b L ORÉAL RECHERCHE   (France)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

High performance liquid chromatography; Penetration; Quantitative determination of clobetasol propionate; Tape stripping; Vehicle influence

Indexed keywords

CLOBETASOL PROPIONATE; EMOLLIENT AGENT;

ADHESIVE TAPE STRIPPING; ADULT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STRATUM CORNEUM; TECHNIQUE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOBETASOL; DIFFUSION; EMOLLIENTS; EPIDERMIS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; OINTMENTS; VEHICLES;

EID: 0033061547     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029845     Document Type: Article

References (7)

1. Schaefer H, Redelmeier TE: Skin Barrier. Basel, Karger, 1996, pp 147-150.
2. Perching LK, Silver BS, Krueger GG, Shah VP, Skelley JP: Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm Res 1992;9:45-51.
3. Weigmann H-J, Lademann J, Meffert H, Sterry W: Influence of sunscreen on the spectral energy distribution of ultraviolet radiation in human skin; in Altmeyer P, Hoffmann K, Stuecker M (ed): Skin Cancer and UV Radiation. Berlin, Springer, 1997, pp 357-362.
4. Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty J-P, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL: Bioequivalence of topical dermatological dosage forms - Methods of evaluation of bioequivalence. Pharm Res 1998;15:167-171.
5. Ashworth J,Watson WS,Finlay AY: The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo. Br J Dermatol 1988;119: 351-358.
6. US Department of Health and Human Services: Guidance for Industry, Topical Dermatological Drug Product NDAs and ANDAs - in Vivo Unavailability, Bioequivalence, In Vitro Release, and Associated Studies. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, June 1998.
7. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds): Dermatology in General Medicine. New York, McGraw-Hill, 1993, vol 1, p 1694.